Feedback / Questions
AKTX-102 - Akari Therap
https://www.globenewswire.com/news-release/2026/01/26/3225663/0/en/Akari-Therapeutics-Files-Key-Patent-and-Unveils-Second-ADC-Program-AKTX-102-Targeting-CEACAM5-Expressing-Solid-Tumors.html
Jan 26, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next